Bioforce Nanosciences Holdings Stock Return On Equity
| BFNH Stock | USD 1.09 0.00 0.00% |
BioForce Nanosciences Holdings fundamentals help investors to digest information that contributes to BioForce Nanosciences' financial success or failures. It also enables traders to predict the movement of BioForce Pink Sheet. The fundamental analysis module provides a way to measure BioForce Nanosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioForce Nanosciences pink sheet.
BioForce |
BioForce Nanosciences Holdings Company Return On Equity Analysis
BioForce Nanosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, BioForce Nanosciences Holdings has a Return On Equity of 0.0. This is 100.0% lower than that of the Consumer Defensive sector and 100.0% lower than that of the Packaged Foods industry. The return on equity for all United States stocks is 100.0% lower than that of the firm.
BioForce Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioForce Nanosciences' direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioForce Nanosciences could also be used in its relative valuation, which is a method of valuing BioForce Nanosciences by comparing valuation metrics of similar companies.BioForce Nanosciences is currently under evaluation in return on equity category among its peers.
BioForce Fundamentals
| Return On Asset | -21.84 | |||
| Current Valuation | 50.2 M | |||
| Shares Outstanding | 29.27 M | |||
| Shares Owned By Insiders | 82.29 % | |||
| Price To Earning | (1.52) X | |||
| Price To Book | 866.24 X | |||
| Price To Sales | 3,841 X | |||
| Gross Profit | 4.36 K | |||
| EBITDA | (501.95 K) | |||
| Net Income | (501.95 K) | |||
| Cash And Equivalents | 9.23 K | |||
| Total Debt | 156.87 K | |||
| Debt To Equity | 4.61 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (77.77 K) | |||
| Earnings Per Share | (0.02) X | |||
| Target Price | 0.25 | |||
| Beta | -1.93 | |||
| Market Capitalization | 72.74 M | |||
| Total Asset | 11.14 K | |||
| Retained Earnings | (21 K) | |||
| Working Capital | 14 K | |||
| Current Asset | 15 K | |||
| Current Liabilities | 1 K | |||
| Net Asset | 11.14 K |
About BioForce Nanosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioForce Nanosciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioForce Nanosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioForce Nanosciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.